Literature DB >> 21847426

Rhabdomyolysis with erratic serum creatinin phosphokinase levels: intramuscular injection of haloperidol decanoate.

Premnath Reddy Karre1, Jeetinder Gujral, Ernesto Rodriguez.   

Abstract

A 56-year-old African American female with a history of schizophrenia developed rhabdomyolysis with creatine phosphokinase (CPK) levels of 5172 U/L after intramuscular injection of haloperidol decanoate. The patient was admitted to the hospital and treated with saline infusion alone. Serum CPK levels were decreased but not significantly so even after 4 days. Renal function tests and vital signs remained normal throughout her stay in the hospital. Urinary alkalinisation was done with sodium bicarbonate to maintain urine pH higher than 6.5 and the CPK levels declined gradually over the next 3 days. The patient was observed for 24 hours without saline infusion and urine alkalinisation but the serum CPK levels continued to increase and this regimen was restarted. The patient stayed in the hospital for 4 weeks on this regimen until the CPK levels decreased and remained normal. Our patient developed rhabdomyolysis without neuroleptic malignant syndrome.

Entities:  

Year:  2009        PMID: 21847426      PMCID: PMC3027372          DOI: 10.1136/bcr.06.2009.1931

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Role of the preoptic-anterior hypothalamus in thermoregulation and fever.

Authors:  J A Boulant
Journal:  Clin Infect Dis       Date:  2000-10       Impact factor: 9.079

Review 2.  Neuroleptic malignant syndrome.

Authors:  P Adnet; P Lestavel; R Krivosic-Horber
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

Review 3.  Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child.

Authors:  H Yoshikawa; T Watanabe; T Abe; Y Oda; K Ozawa
Journal:  Brain Dev       Date:  2000-06       Impact factor: 1.961

4.  Early and vigorous fluid resuscitation prevents acute renal failure in the crush victims of catastrophic earthquakes.

Authors:  Ali Ihsan Gunal; Huseyin Celiker; Ayhan Dogukan; Goksel Ozalp; Ercan Kirciman; Huseyin Simsekli; Izzettin Gunay; Mustafa Demircin; Oktay Belhan; Mustafa A Yildirim; Mehmet S Sever
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121

5.  [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)].

Authors:  M Lazzarin; F Benati; V Cesario
Journal:  Recenti Prog Med       Date:  1996-09

6.  Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?

Authors:  V W Henderson; G F Wooten
Journal:  Neurology       Date:  1981-02       Impact factor: 9.910

7.  Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?

Authors:  Carlos V R Brown; Peter Rhee; Linda Chan; Kelly Evans; Demetrios Demetriades; George C Velmahos
Journal:  J Trauma       Date:  2004-06

Review 8.  Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?

Authors:  Ronald J Gurrera
Journal:  Clin Neuropharmacol       Date:  2002 Jul-Aug       Impact factor: 1.592

9.  Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy.

Authors:  S J Marsh; G M Dolson
Journal:  Ren Fail       Date:  1995-07       Impact factor: 2.606

  9 in total
  4 in total

1.  Recurrent exercise-induced rhabdomyolysis due to low intensity fitness exercise in a healthy young patient.

Authors:  Premnath Reddy Karre; Jeetinder Gujral
Journal:  BMJ Case Rep       Date:  2011-04-01

2.  A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19.

Authors:  Keisuke Takada; Yukiyoshi Sada; Masaru Samura; Masashi Matsuura; Naoki Hirose; Takenori Kurata; Fumio Nagumo; Junichi Ishii; Sakura Koshioka; Masaki Uchida; Junki Inoue; Koji Tanikawa; Hiroyuki Kunishima
Journal:  Am J Case Rep       Date:  2022-06-20

Review 3.  Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice.

Authors:  Zacharias G Laoutidis; Kanellos T Kioulos
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530

4.  [Rhabdomyolysis induced by paliperidone palmitate].

Authors:  Beate Klein; Christoph Silberbauer
Journal:  Neuropsychiatr       Date:  2020-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.